Cargando…
Exploiting DNA repair defects in triple negative breast cancer to improve cell killing
BACKGROUND: The lack of molecular targets for triple negative breast cancer (TNBC) has limited treatment options and reduced survivorship. Identifying new molecular targets may help improve patient survival and decrease recurrence and metastasis. As DNA repair defects are prevalent in breast cancer,...
Autores principales: | Lee, Kevin J., Mann, Elise, Wright, Griffin, Piett, Cortt G., Nagel, Zachary D., Gassman, Natalie R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502856/ https://www.ncbi.nlm.nih.gov/pubmed/32994807 http://dx.doi.org/10.1177/1758835920958354 |
Ejemplares similares
-
Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer
por: Lee, Kevin J., et al.
Publicado: (2019) -
REV7 Monomer Is Unable to Participate in Double Strand Break Repair and Translesion Synthesis but Suppresses Mitotic Errors
por: Vassel, Faye M., et al.
Publicado: (2023) -
407 Glucose activates STAT3, promoting XRCC1 expression and increased DNA repair after exogenous challenge
por: Gassman, Natalie R, et al.
Publicado: (2022) -
Activated STAT3 Is a Novel Regulator of the XRCC1 Promoter and Selectively Increases XRCC1 Protein Levels in Triple Negative Breast Cancer
por: Wright, Griffin, et al.
Publicado: (2021) -
Glucose Increases STAT3 Activation, Promoting Sustained XRCC1 Expression and Increasing DNA Repair
por: Wright, Griffin M., et al.
Publicado: (2022)